Literature DB >> 9399754

High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus.

C C Cronin1, A Feighery, J B Ferriss, C Liddy, F Shanahan, C Feighery.   

Abstract

OBJECTIVES: Diagnosis of unrecognized celiac disease is potentially important. The prevalence of celiac disease in patients with insulin-dependent diabetes mellitus is uncertain. We report the prevalence of celiac disease in a stratified random sample (n = 101) of adult insulin-dependent diabetic patients (age, 18-59 yr) attending our clinic, and in an age- and sex-matched control group (n = 51).
METHODS: Screening was by anti-endomysial antibody, measured by indirect immunofluorescence using sections of human umbilical cord.
RESULTS: Celiac disease had not been suspected in any patient at the time of screening. Eight patients tested positive for anti-endomysial antibody, all of whom had a distal duodenal biopsy performed. Five patients had histologic evidence of celiac disease. One patient with negative histology was receiving immunosuppressive therapy for a renal-pancreas transplant. Of the five patients with abnormal histology, two improved on gluten restriction, one was unable to comply, one refused treatment, and one was lost to follow-up. No control subject tested positive for endomysial antibody.
CONCLUSIONS: Patients with insulin-dependent diabetes have an increased prevalence of celiac disease. Because most cases are clinically unrecognized, consideration should be given to screening all insulin-dependent diabetes mellitus patients with endomysial antibodies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399754

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

Review 1.  Celiac disease. CME update for family physicians.

Authors:  Shane M Devlin; Christopher N Andrews; Paul L Beck
Journal:  Can Fam Physician       Date:  2004-05       Impact factor: 3.275

2.  Screening for celiac disease in average-risk and high-risk populations.

Authors:  Saurabh Aggarwal; Benjamin Lebwohl; Peter H R Green
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

Review 3.  Detecting shared pathogenesis from the shared genetics of immune-related diseases.

Authors:  Alexandra Zhernakova; Cleo C van Diemen; Cisca Wijmenga
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

4.  Anti-endomysial antibody of IgG1 isotype detection strongly increases the prevalence of coeliac disease in patients affected by type I diabetes mellitus.

Authors:  A Picarelli; L Sabbatella; M Di Tola; S Vetrano; C Casale; M C Anania; B Porowska; M Vergari; R Schiaffini; P Gargiulo
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

5.  Physician awareness of celiac disease: a need for further education.

Authors:  Robert D Zipser; Mary Farid; Donald Baisch; Bhairavi Patel; Devika Patel
Journal:  J Gen Intern Med       Date:  2005-07       Impact factor: 5.128

Review 6.  Celiac disease-associated autoimmune endocrinopathies.

Authors:  V Kumar; M Rajadhyaksha; J Wortsman
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

Review 7.  Celiac disease in children and adolescents: special considerations.

Authors:  Kimberly P Newton; Shereen A Singer
Journal:  Semin Immunopathol       Date:  2012-05-02       Impact factor: 9.623

8.  Interaction between psychiatric and autoimmune disorders in coeliac disease patients in the Northeastern United States.

Authors:  S Garud; D Leffler; M Dennis; J Edwards-George; D Saryan; S Sheth; D Schuppan; S Jamma; C P Kelly
Journal:  Aliment Pharmacol Ther       Date:  2009-04-15       Impact factor: 8.171

9.  Patients with celiac disease have a lower prevalence of non-insulin-dependent diabetes mellitus and metabolic syndrome.

Authors:  Toufic A Kabbani; Ciaran P Kelly; Rebecca A Betensky; Joshua Hansen; Kumar Pallav; Javier A Villafuerte-Gálvez; Rohini Vanga; Rupa Mukherjee; Aileen Novero; Melinda Dennis; Daniel A Leffler
Journal:  Gastroenterology       Date:  2013-01-24       Impact factor: 22.682

10.  Cost-effectiveness of universal serologic screening to prevent nontraumatic hip and vertebral fractures in patients with celiac disease.

Authors:  K T Park; Raymond Tsai; Louise Wang; Nasim Khavari; Laura Bachrach; Dorsey Bass
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-26       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.